Selegiline
Selegiline (Emsam) is a monoamine oxidase inhibitor used in two listed tablet products, Emsam and Eldepryl, for major depressive disorder and Parkinson’s disease.
Key points
- Different uses by brand: Emsam is listed for major depressive disorder, while Eldepryl is listed for Parkinson’s disease.
- Listed strengths: Emsam is shown at 5 mg; Eldepryl is shown at 5 mg and 10 mg.
- Shared originator: Both listings name Somerset Pharmaceuticals as the originator.
How Selegiline works
Selegiline is a monoamine oxidase inhibitor. Monoamine oxidase is an enzyme that breaks down certain chemical messengers; reducing its activity changes how they are handled in the brain. In product searches, selegiline identifies the ingredient rather than either brand.

